CLOV vs COKE · rev $1.37B vs P/E 24, rev $7.23B
Clover Health Investments Corp (CLOV) versus Coca-Cola Consolidated Inc. (COKE) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Coca-Cola Consolidated Inc. (COKE) is a beverages - non-alcoholic company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported COKE revenue for 2025-12-31 was $7.23B. Net income was $570.6M. Revenue was up 4.8% from 2024-12-31 to 2025-12-31. COKE currently screens at market cap $11.53B and trailing P/E 23.8.
CLOV currently screens at market cap $1.55B. COKE currently screens at market cap $11.53B and trailing P/E 23.8.
Not investment advice. Open the CLOV and COKE stock pages for the full models.
Not investment advice.